GP-40081 (insulin aspart biphasic biosimilar)
/ Geropharm
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 15, 2020
Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients
(clinicaltrials.gov)
- P3; N=264; Active, not recruiting; Sponsor: Geropharm; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
February 12, 2020
Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients
(clinicaltrials.gov)
- P3; N=264; Recruiting; Sponsor: Geropharm; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open
January 13, 2020
Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients
(clinicaltrials.gov)
- P3; N=264; Not yet recruiting; Sponsor: Geropharm
Clinical • New P3 trial
1 to 3
Of
3
Go to page
1